Cargando…

Mortality trends among people with hepatitis B and C: a population-based linkage study, 1993-2012

BACKGROUND: This study evaluated cause-specific mortality trends including liver-related mortality among people with a hepatitis B virus (HBV) and hepatitis C virus (HCV) notification in New South Wales, Australia. METHODS: Notifications 1993-2012 were linked to cause-specific mortality records 1993...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alavi, Maryam, Grebely, Jason, Hajarizadeh, Behzad, Amin, Janaki, Larney, Sarah, Law, Matthew G., George, Jacob, Degenhardt, Louisa, Dore, Gregory J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944091/ https://www.ncbi.nlm.nih.gov/pubmed/29743015 http://dx.doi.org/10.1186/s12879-018-3110-0

Ejemplares similares

Survival following hospitalization with hepatocellular carcinoma among people notified with hepatitis B or C virus in Australia (2000‐2014)
por: Waziry, Reem, et al.
Publicado: (2017)

Timely Hepatitis C RNA Testing and Treatment in the Era of Direct-Acting Antiviral Therapy among People with Hepatitis C in New South Wales, Australia
por: Yousafzai, Mohammad T., et al.
Publicado: (2022)

Trends in decompensated cirrhosis and hepatocellular carcinoma among people with a hepatitis B notification in New South Wales
por: Shah, Syed Hassan Bin Usman, et al.
Publicado: (2022)

Estimating the number of people who inject drugs in Australia
por: Larney, Sarah, et al.
Publicado: (2017)

A Testing Campaign Intervention Consisting of Peer-Facilitated Engagement, Point-of-Care HCV RNA Testing, and Linkage to Nursing Support to Enhance Hepatitis C Treatment Uptake among People Who Inject Drugs: The ETHOS Engage Study
por: Conway, Anna, et al.
Publicado: (2022)

Trends in all cause and viral liver disease-related hospitalizations in people with hepatitis B or C: a population-based linkage study
por: Gidding, Heather F, et al.
Publicado: (2011)

Australia could miss the WHO hepatitis C virus elimination targets due to declining treatment uptake and ongoing burden of advanced liver disease complications
por: Kwon, Jisoo A., et al.
Publicado: (2021)

Association between opioid agonist therapy use and HIV testing uptake among people who have recently injected drugs: a systematic review and meta‐analysis
por: Ferraro, Claire F., et al.
Publicado: (2021)

HIV infection is associated with higher levels of monocyte chemoattractant protein-1 and eotaxin among people with recent hepatitis C virus infection
por: Lamoury, François M. J., et al.
Publicado: (2016)

Increasing national trend of direct-acting antiviral discontinuation among people treated for HCV 2016–2021
por: Carson, Joanne, et al.
Publicado: (2023)

Alanine aminotransferase, HCV RNA levels and pro-inflammatory and pro-fibrogenic cytokines/chemokines during acute hepatitis C virus infection
por: Hajarizadeh, Behzad, et al.
Publicado: (2016)

Health-related quality of life among people who inject drugs in Australia
por: Cheng, Qinglu, et al.
Publicado: (2023)

The impact of opioid agonist treatment on fatal and non-fatal drug overdose among people with a history of opioid dependence in NSW, Australia, 2001-2018: findings from the OATS retrospective linkage study.
por: Jones, Nicola, et al.
Publicado: (2022)

Protocol for the Data-Linkage Alcohol Cohort Study (DACS): investigating mortality, morbidity and offending among people with an alcohol-related problem using linked administrative data
por: Peacock, Amy, et al.
Publicado: (2019)

Perceptions of extended‐release buprenorphine injections for opioid use disorder among people who regularly use opioids in Australia
por: Larance, Briony, et al.
Publicado: (2020)

Open-label, multicentre, single-arm trial of monthly injections of depot buprenorphine in people with opioid dependence: protocol for the CoLAB study
por: Larance, Briony, et al.
Publicado: (2020)

Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study
por: Cunningham, Evan B., et al.
Publicado: (2017)

Trends in the incidence and mortality of kidney cancer in Lithuania from 1993 to 2012
por: Patašius, Aušvydas, et al.
Publicado: (2018)

“You'll come in and dose even in a global pandemic”: A qualitative study of adaptive opioid agonist treatment provision during the COVID-19 pandemic
por: Conway, Anna, et al.
Publicado: (2023)

Evaluation of the hepatitis C cascade of care among people living with HIV in New South Wales, Australia: A data linkage study
por: Hosseini‐Hooshyar, Samira, et al.
Publicado: (2022)

Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review
por: Degenhardt, Louisa, et al.
Publicado: (2017)

Comparison of Cholangiocarcinoma and Hepatocellular Carcinoma Incidence Trends from 1993 to 2012 in Lampang, Thailand
por: Cao, Pianpian, et al.
Publicado: (2022)

Declining Incidence of Hepatitis C Virus Infection among People Who Inject Drugs in a Canadian Setting, 1996-2012
por: Grebely, Jason, et al.
Publicado: (2014)

Patterns of Hepatitis C Virus RNA Levels during Acute Infection: The InC(3) Study
por: Hajarizadeh, Behzad, et al.
Publicado: (2015)

Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review
por: Larney, Sarah, et al.
Publicado: (2017)

Associations between national development indicators and the age profile of people who inject drugs: results from a global systematic review and meta-analysis
por: Hines, Lindsey A, et al.
Publicado: (2019)

The effect of opioid analgesics, benzodiazepines, gabapentinoids, and opioid agonist treatment on mortality risk among opioid-dependent people.
por: Bharat, Chrianna, et al.
Publicado: (2022)

Elimination of HCV as a public health concern among people who inject drugs by 2030 – What will it take to get there?
por: Grebely, Jason, et al.
Publicado: (2017)

A New Method for Assessing How Sensitivity and Specificity of Linkage Studies Affects Estimation
por: Moore, Cecilia L., et al.
Publicado: (2014)

Quality of Life and Social Functioning during Treatment of Recent Hepatitis C Infection: A Multi-Centre Prospective Cohort
por: Doyle, Joseph S., et al.
Publicado: (2016)

Prison‐based interventions are key to achieving HCV elimination among people who inject drugs in New South Wales, Australia: A modelling study
por: Stone, Jack, et al.
Publicado: (2022)

Trends of non-union and prescriptions for non-steroidal anti-inflammatory drugs in the United States, 1993–2012
por: Wang, Zhong, et al.
Publicado: (2015)

The Rare Cancer Network: achievements from 1993 to 2012.
por: Patel, Ajaykumar, et al.
Publicado: (2012)

Progress Toward Elimination of Onchocerciasis in the Americas — 1993–2012
Publicado: (2013)

The effect of entry and retention in opioid agonist treatment on contact with the criminal justice system among opioid-dependent people: a retrospective cohort study
por: Gisev, Natasa, et al.
Publicado: (2019)

Worldwide trends in breast cancer incidence from 1993 to 2012: Age-period-cohort analysis and joinpoint regression
por: Krishnamoorthy, Yuvaraj, et al.
Publicado: (2020)

Hepatitis B-Related Concerns and Anxieties Among People With Chronic Hepatitis B in Australia
por: Hajarizadeh, Behzad, et al.
Publicado: (2016)

Trends of Obesity in Iranian Adults from 1990s to late 2000s; a Systematic Review and Meta-analysis
por: Mirzazadeh, Ali, et al.
Publicado: (2013)

Managing chronic hepatitis B: A qualitative study exploring the perspectives of people living with chronic hepatitis B in Australia
por: Wallace, Jack, et al.
Publicado: (2011)

The Influence of Hepatitis C Virus Genetic Region on Phylogenetic Clustering Analysis
por: Lamoury, François M. J., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_4q664ch28u755eqv7ois1cn3kq